Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  E-QURE Corp    EQUR

 SummaryQuotesChartsNewsCalendarCompany 
Quotes 5-day view   Delayed Quote. Delayed Otc Bulletin Board - Othe…
10/04/2017 10/05/2017 10/06/2017 10/11/2017 10/12/2017 Date
0.055(c) 0.0785(c) 0(c) 0.079(c) 0.08(c) Last
4 656 10 000 1 1 749 4 000 Volume
-15.86% +42.73% -100.00% +1.27% Change
More quotes
Company
E-QURE Corp. engages in the provision of medical devices.Its product includes the Bioelectrical Signal Therapy, which is used to treat chronic wounds which include Diabetic Foot Ulcers, Pressure (Decubitus) Ulcers, and Vascular (Arterial and Venous) Leg Ulcers.The company was founded on August 31,... 
More about the company
Latest news on E-QURE CORP
08/18 E QURE : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULT..
06/01 E QURE : Was Issued a New Research Report
05/25 E QURE : Electrical Stimulation Therapy and E-Qure - A Potential 20x in 18 Month..
05/15 E QURE : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULT..
03/31 E QURE : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULT..
02/23 E QURE : U.S. FDA Approves Increase in Number of Clinical Sites for E-QURE's Piv..
02/21 E-QURE CORP. (OTCMKTS : EQUR) Files An 8-K Other Events
02/21 E-QURE CORP. : Other Events (form 8-K)
02/15 E-QURE CORP : The Public Health Crisis: Chronic Wounds Cost Lives and $50 Billio..
02/14 E-QURE CORP. (OTCMKTS : EQUR) Files An 8-K Other Events
More news
Sector news : Bio Medical Devices
08:48aDJACTELION : J&J Net Income Falls After Actelion Deal -- WSJ
10/17 Regeneron-Sanofi drug succeeds mid-stage study
10/17DJJOHNSON & JOHNSON : Outlook Buoyed by Drug Unit -- Update
10/17DJJOHNSON & JOHNSON : Raises Guidance on Earnings Beat
10/05DJAppeals Court Rules Against Amgen in Patent Case -- Update
More sector news : Bio Medical Devices
Chart E-QURE CORP
Duration : Period :
E-QURE Corp Technical Analysis Chart | EQUR | US26885P1093 | 4-Traders
Managers
NameTitle
Ohad Goren Chief Executive Officer
Ron Weisburg Chairman
Gal Peleg Chief Financial Officer
Itsik Ben Yesha Chief Technology Officer
Michael Sessler Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
E-QURE CORP-38.46%0
GILEAD SCIENCES11.65%104 788
REGENERON PHARMACEUTICALS20.67%47 421
VERTEX PHARMACEUTICALS107.56%39 091
ACTELION23.24%29 925
INCYTE CORPORATION14.00%24 360